ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

RUA Rua Life Sciences Plc

11.50
0.20 (1.77%)
11 Dec 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Rua Life Sciences Plc LSE:RUA London Ordinary Share GB0033360586 ORD 5P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.20 1.77% 11.50 11.00 12.00 12.25 11.25 11.50 704,699 09:48:08
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Plastics,resins,elastomers 2.19M -1.44M -0.0232 -4.96 7.01M
Rua Life Sciences Plc is listed in the Plastics,resins,elastomers sector of the London Stock Exchange with ticker RUA. The last closing price for Rua Life Sciences was 11.30p. Over the last year, Rua Life Sciences shares have traded in a share price range of 8.65p to 15.50p.

Rua Life Sciences currently has 62,060,272 shares in issue. The market capitalisation of Rua Life Sciences is £7.01 million. Rua Life Sciences has a price to earnings ratio (PE ratio) of -4.96.

Rua Life Sciences Share Discussion Threads

Showing 3551 to 3572 of 3825 messages
Chat Pages: 153  152  151  150  149  148  147  146  145  144  143  142  Older
DateSubjectAuthorDiscuss
10/4/2024
14:44
Can anyone smell BS.
albert35911
10/4/2024
14:32
94000 shares buy just gone through. Big buys arriving
letsbuy1
10/4/2024
08:13
Big push up any sec. They are searching for stock. No float at all
letsbuy1
10/4/2024
07:58
Dropping it to gather shares. Dont give it to them.. this will be 13/14p later today
letsbuy1
09/4/2024
08:26
Timely update.
No horrors for once.
So much potential but can they finally deliver.
My guess is Ian Ardill will be playing a key role in the graft project given his background and experience.
We will see chop with every move up as the placing supporters take their slim gains.
Ultimately, Mr Brown needs to turn this around from the dog it has become, something he mentioned that he would target doing following the name change from AOR.

early not wrong
08/4/2024
12:48
Hopefully see some healthy consolidation around this level before the next leg up.
parob
08/4/2024
08:41
Cavendish retain their 25p price target in their update this morning (with a £7.8m m/cap at 12.5p).

Brief extracts:

"Strong strategic progress

RUA Life Sciences has provided a business update for the year to March 2024, noting revenue shortfalls experienced in H1/24 have been made up by a strong second half. Revenues for the year are therefore expected to be in-line with our forecast £2.2m, while the company notes gross margin will exceed our forecasts, with operating costs remaining tightly controlled.

RUA Life Sciences closed FY24 with cash of c£4.0m versus our £3.3m estimate. The company reports significant progress towards its goal of near-term profitability through growing its contract manufacturing business, noting strong progress with a ‘global enterprise’. Finally, RUA has completed a Material Transfer Agreement with a global Heart Valve company covering its composite heart valve material. We believe this update demonstrates excellent progress against the company’s revised strategy."

"Strategy – As noted with its successful fundraise in December 2023, RUA’s revised strategy will seek to grow its Contract Manufacturing business, generating long-term contract revenues, explore third-party funding for its vascular graft portfolio and pursue licence opportunities for its composite heart valve material. We believe this business update demonstrates strong progress against this strategy.

- Investment thesis – We believe the combination of established revenues with growth potential and the option to deliver significant returns through the disruption of established billion-dollar global cardiovascular markets makes RUA Life Sciences an attractive investment opportunity. RUA now aims to turn profitable in the short term and has adopted a strategy to deliver earlier returns on its Vascular and Structural Heart investments."

rivaldo
07/4/2024
14:00
I think operating costs excludes COS without much doubt. But let's see numbers when they come out
harrogate
07/4/2024
13:00
You may have a point there Harrogate. I was assuming the reference to operating costs was all costs since he paired it with a gross revenue number. These updates always seem to contain a certain amount of ambiguity!
bones
06/4/2024
13:25
Think you need to take off around £400k for cost of sales from that revenue number
harrogate
06/4/2024
12:58
Based on the update, the operating costs for full year to 31/3/24 were approx £3.4M. Assuming that is essentially all of the company’s costs, the operating loss should be around £1.2M using the £2.2M turnover highlighted. It’s not clear if another tax credit is in the offing for these numbers but probably not until later this year.

If it is a £1.2M loss for the year, that is an encouraging change since the interim loss was on its own £1M (after tax credit receipt), meaning the H2 loss was only £200k. We don’t have a lot more to go on though!

Likewise, the loss for the year before (ending 31/3/23) was £2.0M (after tax credit) and this year looks to be £1.2M. Again, a much improved (or less painful) scenario.

Let’s hope the anticipated new business prospects in contract manufacturing continue to build while costs continue to be reduced.

All the while, we hope for partnership developments in heart valve and vascular to manifest themselves!

bones
06/4/2024
08:54
Nice one LITTLE man.

When anyone gets personal it's a sign that they have lost the debate.

Get a life you're such a pathetic LOSER.

Lets remind peeps again this is all to do with you losing £2500 in PPP and you being a THICKO believe it's my fault.

LOL

hahahahahahahahah

z1co
05/4/2024
22:30
Insane volume today. Combined with relative up move in price seems to bode well for further improvement over the coming weeks:


free stock charts from uk.advfn.com

bones
05/4/2024
16:37
Well, possibly, parsons4! He’s keeping his powder dry on the vascular graft side. Will it be possible to find a partner or financier to cover the clinical trials that are sat waiting to go with FDA protocols agreed? At least for now, no more costs of note are needed for that development while it is mothballed.

Let’s hope, like they say they are actively pursuing, that they sign up more “partners̶1; to test the heart valve leaflet material. This product seems to be the possible jewel in the crown or, at least, the diamond in the rough here.

bones
05/4/2024
15:56
Well BB seems to have delivered in terms of catching up for the year and the " heart valve story" is looking good. After the disastrous placing and RNS shenanigans late last year the ship does seem steadier !!! A good close above the placing price also GLA
parsons4
05/4/2024
15:46
purple the clown,

You made no difference at all , thicko try harder next time.

Nice profitable trade.

This game is far too easy for me.

N I C E

z1co
05/4/2024
15:11
CLOWN you're very funny

hahahahahahahah

z1co
05/4/2024
15:10
THATS THE END OF YOUR LITTLE RAMPING GAME

HAHAHAHAH!

purple11
05/4/2024
15:09
YOURE NOT GOING TO BE ABLE TO POST ANYWHERE WITHOUT ME FOLLOWING ALONGSIDE EXPOSING YOU.


HAHAHAHAH!

purple11
05/4/2024
15:04
you meanwhile are losing money all over the shop

YOU ARE A CLOWN

ZICO THE CLOWN

purple11
05/4/2024
15:04
i lost £400 in PPP in total.

just another trade.

purple11
05/4/2024
15:02
You're a loser that's why you wanted a truce.

hahahahahahahahahahah.

THICKO you also lost £2500 in PPP.

hahahahahahahahahahah

z1co
Chat Pages: 153  152  151  150  149  148  147  146  145  144  143  142  Older

Your Recent History

Delayed Upgrade Clock